Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera – single center experience

Lucia MasarovaDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Mohamad CherryDepartment of Hematology and Oncology, The University of Oklahoma Stephenson Cancer Center, Oklahoma City, OK, USA

Kate J. NewberryDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Zeev EstrovDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Jorge E. CortesDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Hagop M. KantarjianDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Srdan VerstovsekDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]

show all

References

Passamonti F, Rumi E, Pungolino E, et al. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med 2004;117:755–761.
PubMed Web of Science ®Google Scholar
Radaelli F, Onida F, Rossi FG, et al. Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution. Hematology (Amsterdam, Netherlands) 2008;13:195–202.
PubMed Web of Science ®Google Scholar
Finazzi G, Ruggeri M, Rodeghiero F, et al. Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial. Br J Haematol 2000;110:577–583.
PubMed Web of Science ®Google Scholar
Vannucchi MA, Masala G, Antonioli E, et al. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome–negative myeloproliferative neoplasms. Cancer Epidemiol Biomarkers Prev 2009;18:2068–2073.
PubMed Web of Science ®Google Scholar
Frederiksen H, Farkas DK, Christiansen CF, et al. Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study. Blood 2011;118(25):6515–6520.
PubMed Web of Science ®Google Scholar
Fallah M, Kharazmi E, Sudquist J, et al. Higher risk of primary cancers after polycythemia vera and vice versa. Br J Haematol 2010;153:273–285.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera – single center experience

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera – single center experience

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date